What question did this study set out to answer?

This review aims to outline capillary blood technologies for measuring HbA1c in epidemiological studies, assessing their practicality and barriers to implementation.

July 13, 2026BMC Endocrine DisordersOpen Access

HbA1c measurement using capillary blood in epidemiological studies: a scoping review of technologies and approaches

View Full Paper

Ask AI

Bookmark

This review aims to outline capillary blood technologies for measuring HbA1c in epidemiological studies, assessing their practicality and barriers to implementation.
Scoping review conducted per PRISMA-ScR guidelines, including studies from multiple databases.
Review considered epidemiological studies utilizing capillary blood for HbA1c assessment without language or location restrictions.
Data extraction and synthesis based on outcomes categorically reported from included studies.
106 studies identified from 2,238 screened records, with 15 distinct analytical technologies reported.
Point-of-Care Testing (PoCT) devices were most used, requiring 2–10 µL of blood, providing rapid results.
Key challenges included analytical performance variability, especially in Low- and Middle-Income Countries.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Scoping review maps capillary blood technologies measuring HbA1c in epidemiological studies, suggesting implications for health systems.

Cite This Study

Breternitz et al. (2026) studied this question.

synapsesocial.com/papers/6a548195475c38bf615a583e https://doi.org/10.1186/s12902-026-02410-y

View Full Paper

Ask AI

Bookmark

HbA1c measurement using capillary blood in epidemiological studies: a scoping review of technologies and approaches

Key Points

Discussion

Implication

Cite This Study

HbA1c measurement using capillary blood in epidemiological studies: a scoping review of technologies and approaches

Key Points

Discussion

Implication

Cite This Study

Keep reading

Keep reading